Patent · US Active

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

US12145927B2 · kind B2 · utility

0Cited by

1References

11Claims

0Family size

Assignee

Bristol-Myers Squibb Company · US

Inventors

James Aaron Balog · Lambertville, US
Steven P. Seitz · Swarthmore, US
Jay A. Markwalder · New London, US
David K. Williams · Cinnaminson, US
Weifang Shan · Princeton, US
Susheel Jethanand Nara · Mumbai, IN
Saumya Roy · Bengaluru, IN
Srinivas Cheruku · Bengaluru, IN
Nagalakshmi Pulicharla · Bengaluru, IN

Key dates

Filing date	Jul 22, 2019
Grant date	Nov 19, 2024
Priority date	—
Expiry date	Feb 6, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K16/2818
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention provides compounds of formula (I) wherein all of the variables are as defined herein. These compounds are inhibitors of indoleamine 2,3-dioxygenase (IDO), which may be used as medicaments for the treatment of proliferative disorders, such as cancer, viral infections and/or autoimmune diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.